KRAS and malignant colon neoplasm: However, available information indicates that each K-Ras mutation (including codons 12 and 13) has a distinct gene/protein profile and is very different in signal pathway activations (Hammond et al., 2015), suggesting a deep understanding of the molecular mechanism of each mutation is essential for guiding more precise and effective treatments of K-Ras mutated colon cancer patients in clinic.